Lamellar Biomedical

About:

Lamellar Biomedical develops novel healthcare products based on the mimicry or modification of the lamellar body secretory system.

Website: http://lamellar.com

Top Investors: Invesco, Pitch@Palace, TRICAPITAL, Scottish Investment Bank, Barwell Plc

Description:

Lamellar Biomedical Ltd was established in June 2007 when the founding Directors of the Company, recognising the considerable therapeutic potential of Lamellasomes™, acquired the intellectual property rights to the technology.

Total Funding Amount:

11.4M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Bellshill, North Lanarkshire, United Kingdom

Founded Date:

2007-06-01

Contact Email:

info(AT)lamellar.com

Founders:

James Dobbie

Number of Employees:

11-50

Last Funding Date:

2017-05-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai